Incidence of Dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana

JAMA

Volumn 285, Issue 6, 2001, Pages 739-747

  Hendrie, Hugh C ^a   Ogunniyi, Adesola ^b   Hall, Kathleen S ^a   Baiyewu, Olusegun ^b   Unverzagt, Frederick W ^a   Gureje, Oye ^b   Gao, Sujuan ^a   Evans, Rebecca M ^a   Ogunseyinde, A O ^b   Adeyinka, A O ^b   Musick, Beverly ^a   Hui, Siu L ^a  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; DEMENTIA; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PRIORITY JOURNAL;

EID: 0035857377     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.6.739     Document Type: Article

References (45)

1. Diagnosis and treatment of Alzheimer disease and related disorders: Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society
2. The US economic and social costs of Alzheimer's disease revisited
3. The need for research on dementia in developing countries
4. The incidence of dementia: A meta-analysis
5. The relationship between age, sex, and the incidence of dementia and Alzheimer disease: A meta-analysis
6. Sources of variability in prevalence rates of Alzheimer's disease
7. The prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans
8. Determination of ages of elderly Nigerians through historical events: Validation of Ajayi-Igun 1963 listing
9. A cross-cultural community based study of dementias: Methods and performance of the survey instrument, Indianapolis, USA, and Ibadan, Nigeria
10. Community Screening Interview for Dementia (CSI"D"): Performance in five disparate study sites
11. CAMDEX: A standardized instrument for the diagnosis of mental disorders in the elderly with special reference to the early detection of dementia
12. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part I: Clinical and neuropsychological assessment of Alzheimer's disease
13. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
14. Age-associated cognitive decline
15. Effects of age, education, and gender on CERAD neuropsychological test performance in an African-American sample
16. The CERAD Neuropsychological Test Battery: Norms from a Yoruba-speaking Nigerian sample
17. A population-based study on the incidence of dementia disorder between 85 and 88 years of age
18. Dementia: Age-dependent incidence, prevalence, and mortality in the old old
19. Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham study
20. The Gospel Oak study, stage III: The incidence of dementia
21. Incidence of dementia in a Munich community sample of the oldest old
22. Very old women at highest risk of dementia and Alzheimer's disease: Incidence data from the Kungsholmen Project, Stockholm
23. Incidence of dementia in the Lundby study
24. Incidence of dementia and Alzheimer's disease in elderly community residents of southwestern France
25. A three year follow-up study of age-related dementia in an urban area of Beijing
26. Incidence of dementia in a representative British sample
27. Incidence of dementia in a population older than 75 years in the United Kingdom
28. Incidence of clinically diagnosed subtypes of dementia in an elderly population: Cambridge Project for Later Life
29. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama study
30. Age-specific incidence of Alzheimer's disease in a community population
31. The APOE-ε 4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics
32. The prevalence and 3-year incidence of dementia in older black and white community residents
33. Estimating the true extent of cognitive decline in the old old
34. Missing data in epidemiological studies of age-associated cognitive decline
35. Apolipoprotein E alleles as risk factors in Alzheimer's disease
36. Apolipoprotein E: Associated risk for Alzheimer disease in the African-American population is genotype dependent
37. Apolipoprotein E and Alzheimer's disease: Ethnic variation in genotypic risks
38. Lack of an association between the E4 allele of ApoE and Alzheimer's disease in elderly Nigerians
39. Epidemiology of dementia in Nigeria: Results from the Indianapolis-Ibadan study
40. Brain infarction and the clinical expression of Alzheimer's disease: The Nun Study
41. The interaction between vascular disorders and Alzheimer's disease
42. Vascular disease and vascular risk factors and dementia